ICU Medical, Inc. (NASDAQ:ICUI) Chairman Vivek Jain sold 2,205 shares of the stock in a transaction dated Tuesday, October 10th. The shares were sold at an average price of $190.91, for a total transaction of $420,956.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Vivek Jain also recently made the following trade(s):

  • On Monday, October 9th, Vivek Jain sold 2,200 shares of ICU Medical stock. The shares were sold at an average price of $190.91, for a total transaction of $420,002.00.

ICU Medical, Inc. (ICUI) traded down 0.80% during midday trading on Wednesday, hitting $187.05. 98,293 shares of the company’s stock traded hands. The company has a market capitalization of $3.71 billion, a PE ratio of 74.91 and a beta of 0.35. The company has a 50 day moving average of $180.38 and a 200-day moving average of $168.02. ICU Medical, Inc. has a 52 week low of $127.00 and a 52 week high of $192.65.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). The company had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company’s revenue for the quarter was up 242.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.15 EPS. Equities research analysts predict that ICU Medical, Inc. will post $4.11 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/11/insider-selling-icu-medical-inc-icui-chairman-sells-2205-shares-of-stock.html.

Several equities research analysts have issued reports on ICUI shares. Zacks Investment Research raised shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Wednesday. BidaskClub cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research note on Thursday, August 24th. Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. Finally, Sidoti cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. ICU Medical presently has a consensus rating of “Hold” and a consensus target price of $193.00.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its stake in ICU Medical by 0.6% in the 2nd quarter. BlackRock Inc. now owns 1,780,976 shares of the medical instruments supplier’s stock worth $307,218,000 after purchasing an additional 11,046 shares in the last quarter. Janus Capital Management LLC increased its stake in ICU Medical by 178.8% in the 1st quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after purchasing an additional 923,395 shares in the last quarter. Janus Henderson Group PLC purchased a new position in ICU Medical in the 2nd quarter worth about $247,072,000. Vanguard Group Inc. increased its stake in ICU Medical by 16.3% in the 2nd quarter. Vanguard Group Inc. now owns 1,304,282 shares of the medical instruments supplier’s stock worth $224,989,000 after purchasing an additional 183,133 shares in the last quarter. Finally, Wellington Management Group LLP increased its stake in ICU Medical by 12.1% in the 1st quarter. Wellington Management Group LLP now owns 652,897 shares of the medical instruments supplier’s stock worth $99,697,000 after purchasing an additional 70,283 shares in the last quarter. 78.13% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.